🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
HyPeR is a multi-centre Phase 1 Dose Escalation Study of Guadecitabine (SGI...
Status
Active Not Recruiting
Location
Royal Marsden Hospital
Start Date
2017-01-26
Trial ID
NCT02998567
Treatments Being Tested
This is a phase I/II study of the combination of Guadecitabine (SGI-110) an...
Status
Completed
Location
USC / Norris Comprehensive Cancer Center
Start Date
2013-10-23
Trial ID
NCT01896856
Treatments Being Tested
Thi pahse I, dose-escalation trial will determine the MTD, safety and the a...
Status
Unknown
Location
Medical Oncology and Immunotherapy Unit, University Hospital of Siena
Start Date
2015-10
Trial ID
NCT02608437
Treatments Being Tested
The purpose of this study is to find the best way to combine a new chemothe...
Status
Completed
Location
University of Maryland Greenebaum Comprehensive Cancer Center
Start Date
2016-08
Trial ID
NCT02878785
Treatments Being Tested
Phase 1-2 dose-escalation randomized study in participants with intermediat...
Status
Completed
Location
Mayo Clinic
Start Date
2011-01-04
Trial ID
NCT01261312
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of guadecitab...
Status
Withdrawn
Location
USC / Norris Comprehensive Cancer Center
Start Date
2020-01-30
Trial ID
NCT03576963
Treatments Being Tested
The purpose of this study is to determine if a combination of investigation...
Status
Completed
Location
Columbia University Medical Center
Start Date
2017-12-15
Trial ID
NCT03085849
Treatments Being Tested
A 2-part, Phase 2 controlled, open-label, randomized study in participants ...
Status
Completed
Location
Norris Comprehensive Cancer Center- University of Southern California
Start Date
2012-09
Trial ID
NCT01696032